A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206
Crossref DOI link: https://doi.org/10.1371/journal.pone.0193344
Published Online: 2018-02-22
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Chorner, Paige M.
Moorehead, Roger A. https://orcid.org/0000-0001-9539-6295
Funding for this research was provided by:
Canadian Cancer Society Research Institute (702006)
Version of Record valid from 2018-02-22
